PROCEEDINGS VOLUME 2675
PHOTONICS WEST '96 | JAN 27 - FEB 2 1996
Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy V
IN THIS VOLUME

0 Sessions, 30 Papers, 0 Presentations
Clinical  (8)
PHOTONICS WEST '96
Jan 27 - Feb 2 1996
San Jose, CA, United States
Clinical
Proc. SPIE 2675, Effect of Photofrin on skin reflection of basal cell nevus syndrome patients, 0000 (2 April 1996); doi: 10.1117/12.237521
Proc. SPIE 2675, Photodynamic therapy and the treatment of malignancies of the head and neck, 0000 (2 April 1996); doi: 10.1117/12.237529
Proc. SPIE 2675, Photodynamic therapy in Barrett's esophagus: review of current results, 0000 (2 April 1996); doi: 10.1117/12.237536
Proc. SPIE 2675, Photodynamic therapy for skin cancer, 0000 (2 April 1996); doi: 10.1117/12.237545
Proc. SPIE 2675, Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status, 0000 (2 April 1996); doi: 10.1117/12.237548
Proc. SPIE 2675, SnET2: clinical update, 0000 (2 April 1996); doi: 10.1117/12.237549
Proc. SPIE 2675, Hematoporphyrin-mediated photodynamic therapy for treatment of head and neck cancer: clinical update 1996, 0000 (2 April 1996); doi: 10.1117/12.237550
Proc. SPIE 2675, Accumulation of hypericin in human gastric tumors, 0000 (2 April 1996); doi: 10.1117/12.237522
Detection/Dosimetry
Proc. SPIE 2675, On-line dosimetry for photodynamic therapy: part I--incident irradiance versus space irradiance for human skin, 0000 (2 April 1996); doi: 10.1117/12.237523
Proc. SPIE 2675, Photodynamic drug detection system for measurement of drug uptake, 0000 (2 April 1996); doi: 10.1117/12.237524
Proc. SPIE 2675, Fluorescence photodiagnosis for malignant tumor, 0000 (2 April 1996); doi: 10.1117/12.237525
Proc. SPIE 2675, New method to calculate back-reflected radiance for isotropic scattering, 0000 (2 April 1996); doi: 10.1117/12.237526
Mechanisms in Photodynamic Therapy
Proc. SPIE 2675, Effects of indocyanine green in treatment of murine mammary tumor by an 808-nm diode laser: an in-vivo study, 0000 (2 April 1996); doi: 10.1117/12.237527
Proc. SPIE 2675, Photodynamic therapy (PDT) as a biological modifier, 0000 (2 April 1996); doi: 10.1117/12.237528
Proc. SPIE 2675, Modulation of PDT-induced apoptosis by protein kinases and phosphatases, 0000 (2 April 1996); doi: 10.1117/12.237530
Proc. SPIE 2675, Photobleaching of native and exogenous (BPD-MA) fluorescence: an in-vivo tumor-bearing rat model, 0000 (2 April 1996); doi: 10.1117/12.237531
Proc. SPIE 2675, Photodynamic therapy: computer modeling of diffusion and reaction phenomena, 0000 (2 April 1996); doi: 10.1117/12.237532
Proc. SPIE 2675, Modulation of tumor response to photodynamic therapy in severe combined immunodeficient (SCID) mice by adoptively transferred lymphoid cells, 0000 (2 April 1996); doi: 10.1117/12.237533
Proc. SPIE 2675, Diffusion and localization of hematoporphyrin derivative in the normal bladder wall of a pig and a rat after local administration, 0000 (2 April 1996); doi: 10.1117/12.237534
New Photosensitizers
Proc. SPIE 2675, Influence of drug and light regimens in determining PDT efficacy with lutetium texaphyrin, 0000 (2 April 1996); doi: 10.1117/12.237535
Proc. SPIE 2675, Functionalized benzochlorins for PDT, 0000 (2 April 1996); doi: 10.1117/12.237537
Proc. SPIE 2675, Cyanopurpurins: synthesis from meso-(2-cyanovinyl)porphyrins, 0000 (2 April 1996); doi: 10.1117/12.237538
Proc. SPIE 2675, Synthesis of N-alkylated chlorins, 0000 (2 April 1996); doi: 10.1117/12.237539
Proc. SPIE 2675, Selective synthesis and characterization of chlorins as sensitizers for photodynamic therapy, 0000 (2 April 1996); doi: 10.1117/12.237540
Proc. SPIE 2675, Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 (NPe6), 0000 (2 April 1996); doi: 10.1117/12.237541
Proc. SPIE 2675, Photochemistry of triarylmethane dyes bound to proteins, 0000 (2 April 1996); doi: 10.1117/12.237542
Proc. SPIE 2675, Protoporphyrin IX distribution after intra-articular and systemic application of 5-aminolevulinic acid in healthy and arthritic joints, 0000 (2 April 1996); doi: 10.1117/12.237543
Proc. SPIE 2675, Energetics of chlorins: a potent photosensitizer of PDT, 0000 (2 April 1996); doi: 10.1117/12.237544
Poster Session
Proc. SPIE 2675, New sensitizers and rapid monitoring of their photodynamic activity, 0000 (2 April 1996); doi: 10.1117/12.237546
Detection/Dosimetry
Proc. SPIE 2675, Intra-arterial PDT and ordinary PDT in head and neck cancer, 0000 (2 April 1996); doi: 10.1117/12.237547
Back to Top